Cunningham Ann Michelle 4
4 · VistaGen Therapeutics, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Cunningham Ann Michelle
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+150,000→ 150,000 totalExercise: $1.37Exp: 2032-03-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan. Twenty-five percent (25%) of the total number of shares vest immediately on March 1, 2022 (the "Vesting Start Date") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.